Belkin Vision, An Israeli Startup, Will Offer Fast, Non Invasive Treatment For Glaucoma

Belkin Vision, An Israeli Startup, Will Offer Fast, Non Invasive Treatment For Glaucoma

140 million individuals worldwide have Glaucoma or Ocular High Blood Pressure with 80% of these clients in emerging economies. Glaucoma is incurable however with treatment its progression can be postponed.

Belkin Vision, an Israeli startup is working on making quickly, non-invasive treatment accessible for everybody by automating the SLT treatment. An innovative algorithm finds the treatment area and with just a press of a button, 120 lasers are delivered to the eye at the speed of light.

This innovation is presently going through scientific trials and Daria Lemann Blumenthall, CEO of Belkin Vision believes that this device might be offered by end of next year.

Since DSLT does not need innovative abilities, it can likewise be provided by cataract surgeons, basic ophthalmologists and eye doctors, enabling a bigger population to get this treatment immediately.

Watch the video listed below to hear Daria Lemann Blumenthall talk about DSLT in more detail.

The most popular treatment for Glaucoma is eye drops that require to be taken every day multiple times for the rest of an individuals life. Due to the fact that of the accuracy required, SLT is not readily available as a first line of treatment for all Glaucoma patients.

Source: I24 News, Belkin Vision

The most popular treatment for Glaucoma is eye drops that need to be taken every day multiple times for the rest of a persons life. Selective Laser Trabeculoplasty (SLT) is another treatment– a treatment that is invasive and needs advanced skill and precision to deliver hundred different laser shots to the eye for at least 5 minutes. Due to the fact that of the precision required, SLT is not available as a first line of treatment for all Glaucoma patients.

Related